Two Sigma Investments »

Contineum Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $446k 38k 11.75
2025-06-30 $242k 61k 3.97

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Contineum Therapeutics

RA Capital Management
Johnson & Johnson
Suvretta Capital Management
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Samsara BioCapital
Versant Venture Management
Point72 Asset Management

View all funds holding Contineum Therapeutics